Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -4.04 is 84% below its 5-year average of -2.20, near the low end of its 5-year range (-6.47–7.17).
3.58% above its 12-month average of -4.19.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.22.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:38:26.904Z. Historical observations retain their original dates. Historical series through 2022-08-08.
EARNINGS PER SHARE (EPS)
-4.04
EARNINGS PER SHARE (EPS) AVG TTM
-4.19
EARNINGS PER SHARE (EPS) AVG 3Y
-4.39
EARNINGS PER SHARE (EPS) AVG 5Y
-2.20
EARNINGS PER SHARE (EPS) AVG 10Y
-2.56
EARNINGS PER SHARE (EPS) AVG 15Y
-2.77
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.58%
CURRENT VS 3Y AVG
+7.97%
CURRENT VS 5Y AVG
-83.64%
CURRENT VS 10Y AVG
-57.64%
CURRENT VS 15Y AVG
-45.89%
CURRENT VS 20Y AVG
N/A
uniQure N.V.
Market Cap
$1.60B
Earnings Per Share (EPS)
-4.04
TTM Avg
-4.19
3Y Avg
-4.39
5Y Avg
-2.20
Market Cap
$1.61B
Earnings Per Share (EPS)
-1.42
TTM Avg
-1.32
3Y Avg
-1.19
5Y Avg
-1.40
Market Cap
$1.61B
Earnings Per Share (EPS)
-0.54
TTM Avg
-1.52
3Y Avg
-1.00
5Y Avg
-1.00
Market Cap
$1.59B
Earnings Per Share (EPS)
-2.67
TTM Avg
-2.43
3Y Avg
-2.07
5Y Avg
-2.07
Market Cap
$1.61B
Earnings Per Share (EPS)
0.84
TTM Avg
0.16
3Y Avg
0.00
5Y Avg
0.42
Market Cap
$1.62B
Earnings Per Share (EPS)
-0.72
TTM Avg
-1.04
3Y Avg
-1.27
5Y Avg
-1.30
Market Cap
$1.63B
Earnings Per Share (EPS)
4.63
TTM Avg
1.23
3Y Avg
0.09
5Y Avg
-0.82
Market Cap
$1.57B
Earnings Per Share (EPS)
-3.36
TTM Avg
-0.89
3Y Avg
-1.69
5Y Avg
-1.77
Market Cap
$1.54B
Earnings Per Share (EPS)
-2.52
TTM Avg
-3.51
3Y Avg
-3.12
5Y Avg
-2.29
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| uniQure N.V. (QURE) | $1.60B | -4.04 | -4.19 | -4.39 | -2.20 |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | -1.42 | -1.32 | -1.19 | -1.40 |
| Septerna Inc (SEPN)vs › | $1.61B | -0.54 | -1.52 | -1.00 | -1.00 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -2.67 | -2.43 | -2.07 | -2.07 |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 0.84 | 0.16 | 0.00 | 0.42 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | -0.72 | -1.04 | -1.27 | -1.30 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 4.63 | 1.23 | 0.09 | -0.82 |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -3.36 | -0.89 | -1.69 | -1.77 |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -2.52 | -3.51 | -3.12 | -2.29 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 4.10 | 2.19 | 2.59 | 2.64 |
Trailing EPS (TTM)
$-4.04
Forward EPS (Est.)
$-3.89
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.46 |
| 2024-12-31 | -4.92 |
| 2023-12-31 | -6.47 |
| 2022-12-31 | -2.71 |
| 2021-12-31 | 7.17 |
| 2020-12-31 | -2.81 |
| 2019-12-31 | -3.20 |
| 2018-12-31 | -2.34 |
| 2017-12-31 | -2.98 |
| 2016-12-31 | -2.93 |
| 2015-12-31 | -3.54 |
| 2014-12-31 | -2.63 |
| 2013-12-31 | -2.10 |
| 2012-12-31 | -1.11 |
| 2011-12-31 | -1.27 |
